Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Russel

Showing results (131-140 of 139) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 139 results.
Gut|September 10, 2005
Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohortF L Wolters, M G Russel, J Sijbrandij, et al.
Scandinavian Journal of Gastroenterology. Supplement|June 20, 2006
Disease outcome of inflammatory bowel disease patients: general outline of a Europe-wide population-based 10-year clinical follow-up studyFrank L Wolters, Maurice G Russel, Jildou Sijbrandij, et al.
Gastroenterology|September 6, 2006
Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluationSelwyn Odes, Hillel Vardi, Michael Friger, et al.
Gut|December 20, 2005
Phenotype at diagnosis predicts recurrence rates in Crohn's diseaseF L Wolters, M G Russel, J Sijbrandij, et al.
Scandinavian Journal of Gastroenterology|June 18, 2019
Limited relevance and progression of histological alterations in the liver during thioguanine therapy in inflammatory bowel disease patientsDirk P van Asseldonk, Melek Simsek, Nanne K H de Boer, et al.
Inflammatory Bowel Diseases|August 3, 2016
The Prevalence of Nodular Regenerative Hyperplasia in Inflammatory Bowel Disease Patients Treated with Thioguanine Is Not Associated with Clinically Significant Liver DiseaseDirk P van Asseldonk, Bindia Jharap, Joanne Verheij, et al.
Scandinavian Journal of Gastroenterology|March 14, 2007
Treatment inferred disease severity in Crohn's disease: evidence for a European gradient of disease courseFrank L Wolters, Catelijne Joling, Maurice G Russel, et al.
Gut|October 23, 2013
Treatment of bone loss in osteopenic patients with Crohn's disease: a double-blind, randomised trial of oral risedronate 35 mg once weekly or placebo, concomitant with calcium and vitamin D supplementationAd A van Bodegraven, Nathalie Bravenboer, Birgit I Witte, et al.
Journal of Crohn'S & Colitis|October 20, 2020
Clinical Outcomes of Covid-19 in Patients With Inflammatory Bowel Disease: A Nationwide Cohort StudyLauranne A A P Derikx, Marten A Lantinga, Dirk J de Jong, et al.
Pageof 14

Showing results (131-140 of 139) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 139 results.
Gut|September 10, 2005
Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohortF L Wolters, M G Russel, J Sijbrandij, et al.
Scandinavian Journal of Gastroenterology. Supplement|June 20, 2006
Disease outcome of inflammatory bowel disease patients: general outline of a Europe-wide population-based 10-year clinical follow-up studyFrank L Wolters, Maurice G Russel, Jildou Sijbrandij, et al.
Gastroenterology|September 6, 2006
Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluationSelwyn Odes, Hillel Vardi, Michael Friger, et al.
Gut|December 20, 2005
Phenotype at diagnosis predicts recurrence rates in Crohn's diseaseF L Wolters, M G Russel, J Sijbrandij, et al.
Scandinavian Journal of Gastroenterology|June 18, 2019
Limited relevance and progression of histological alterations in the liver during thioguanine therapy in inflammatory bowel disease patientsDirk P van Asseldonk, Melek Simsek, Nanne K H de Boer, et al.
Inflammatory Bowel Diseases|August 3, 2016
The Prevalence of Nodular Regenerative Hyperplasia in Inflammatory Bowel Disease Patients Treated with Thioguanine Is Not Associated with Clinically Significant Liver DiseaseDirk P van Asseldonk, Bindia Jharap, Joanne Verheij, et al.
Scandinavian Journal of Gastroenterology|March 14, 2007
Treatment inferred disease severity in Crohn's disease: evidence for a European gradient of disease courseFrank L Wolters, Catelijne Joling, Maurice G Russel, et al.
Gut|October 23, 2013
Treatment of bone loss in osteopenic patients with Crohn's disease: a double-blind, randomised trial of oral risedronate 35 mg once weekly or placebo, concomitant with calcium and vitamin D supplementationAd A van Bodegraven, Nathalie Bravenboer, Birgit I Witte, et al.
Journal of Crohn'S & Colitis|October 20, 2020
Clinical Outcomes of Covid-19 in Patients With Inflammatory Bowel Disease: A Nationwide Cohort StudyLauranne A A P Derikx, Marten A Lantinga, Dirk J de Jong, et al.
Pageof 14